ArticleThrombosis journal2026
Relapsing polychondritis in a patient with suspected antiphospholipid syndrome presenting with inferior vena cava thrombosis: Palestinian case report.
Article in Thrombosis journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntiphospholipid syndrome (APS) is an autoimmune thrombophilia characterized by arterial and venous thrombosis that commonly affects the deep veins of the lower extremities and cerebral vasculature. Inferior vena cava (IVC) thrombosis is an extremely rare manifestation of APS and is often associated with hypercoagulable states. Relapsing polychondritis (RPC) is an autoimmune disorder affecting cartilaginous structures, sometimes occurring alongside APS. However, the coexistence of primary suspected APS and RPC has rarely been reported. CASE PRESENTATION: A 33-year-old previously healthy male who presented with fever, acute right-sided flank pain, and systemic symptoms. Initial evaluation revealed urolithiasis, but persistent pain and elevated inflammatory markers prompted further imaging, which revealed IVC thrombosis.
conclusionThis case highlights the importance of recognizing suspected APS in patients presenting with unprovoked IVC thrombosis and highlights RPC as a potential autoimmune comorbidity. Although APS is a well-established prothrombotic disorder, its coexistence with RPC remains uncommon and poorly understood. The presence of antiphospholipid antibodies may contribute to the vascular inflammation observed in RPCs, suggesting a possible pathogenic link between these two conditions. Further studies are needed to explore the relationship between APS and RPC and refine diagnostic and therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.